Phogen
Industry
- Pharmaceuticals
- Biotechnology
Latest on Phogen
The UK biotech Antikor Biopharma Ltd. is engineering antibody fragments to carry multiple anticancer payloads that may be of use in the treatment of solid tumors, a sector not yet adequately address
by Sharon O’Reilly Long considered the "sweet spot" in the musculoskeletal industry, the market for spine implants and products will surpass $6 billion in global revenues this year. While technologica
by Sharon O’Reilly As robust and innovative as ever, the market for spinal implants and instruments grew by more than 17% last year and now exceeds $6 billion in worldwide revenues. While products for
by Tracy Neilssien Orthopedics/Spine Medtronic Inc. (Minneapolis, MN) has received investigational device exemption (IDE) approval from the FDA to conduct a clinical trial of its Infuse bone graft,